Tower Research Capital LLC (Trc) Spring Works Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,931 shares of SWTX stock, worth $437,976. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,931
Previous 3,834
132.94%
Holding current value
$437,976
Previous $122,000
163.93%
% of portfolio
0.01%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$351 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$276 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$170 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$161 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$147 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.06B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...